Landfar Bio-medicine Co., Ltd (SZSE: 000504)
Health Care · Biotechnology · CN
CN¥8.43
-4.64% today · -14.0% 1Y
Landfar Bio-medicine Co., Ltd (SZSE: 000504) operates in the Biotechnology industry within the Health Care sector. The company is valued at $413.85M and employs 316 people.
Over the last twelve months the share price has lost 14.0%, trading between 7.02 and 10.81.
Tweenvest scores Landfar Bio-medicine Co., Ltd across four factors: quality 60/100, value 48/100, growth 100/100. Its strongest factor is growth.
000504 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $413.85M
- Revenue (TTM)
- $74.35M
- P/E
- 64.03
- EPS
- 0.13
- Dividend yield
- —
- Beta (5Y)
- 0.39
- 52-week high
- CN¥10.81
- 52-week low
- CN¥7.02
- Avg volume (3M)
- —
- Shares outstanding
- 330.02M
- Employees
- 316
- Next earnings
- —
About Landfar Bio-medicine Co., Ltd
Landfar Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It also involves in the storage of biological resources, stem cells and immune cells. The company was founded in November 1988 and is headquartered in Changsha, China.
- ISIN
- CNE000000263
- Founded
- 1991
- Listed since
- Dec 8, 1992
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.